SEARCH

SEARCH BY CITATION

References

  • Alexander SP, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edition. Br J Pharmacol 153 (Suppl. 2): S1209.
  • Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK et al. (2006). Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 368: 733743.
  • Ataga KI, Orringer EP, Styles L, Vichinsky EP, Swerdlow P, Davis GA et al. (2006). Dose-escalation study of ICA-17043 in patients with sickle cell disease. Pharmacotherapy 26: 15571564.
  • Ataga KI, Smith WR, De Castro LM, Swerdlow P, Saunthararajah Y, Castro O et al. (2008). Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia. Blood 111: 39913997.
  • Azam P, Sankaranarayanan A, Homerick D, Griffey S, Wulff H (2007). Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis. J Invest Dermatol 127: 14191429.
  • Barnes PJ, Adcock IM (2003). How do corticosteroids work in asthma? Ann Intern Med 139: 359370.
  • Beeton C, Wulff H, Barbaria J, Clot-Faybesse O, Pennington M, Bernard D et al. (2001). Selective blockade of T lymphocyte K+ channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. PNAS 98: 1394213947.
  • Beeton C, Wulff H, Singh S, Botsko S, Crossley G, Gutman GA et al. (2003). A novel fluorescent toxin to detect and investigate Kv1.3 channel up-regulation in chronically activated T lymphocytes. J Biol Chem 278: 99289937.
  • Beeton C, Pennington MW, Wulff H, Singh S, Nugent D, Crossley G et al. (2005). Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases. Mol Pharmacol 67: 13691381.
  • Beeton C, Wulff H, Standifer NE, Azam P, Mullen KM, Pennington MW et al. (2006). Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. PNAS 103: 1741417419.
  • Begenisich T, Nakamoto T, Ovitt CE, Nehrke K, Brugnara C, Alper SL et al. (2004). Physiological roles of the intermediate conductance, Ca2+-activated potassium channel Kcnn4. J Biol Chem 279: 4768147687.
  • Berridge MJ, Lipp P, Bootman MD, Berridge MJ, Lipp P, Bootman MD (2000). The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1: 1121.
  • Berry MA, Hargadon B, Shelley M, Parker D, Shaw DE, Green RH et al. (2006). Evidence of a role of TNFα in refractory asthma. N Engl J Med 354: 697708.
  • Boulet LP (2003). Physiopathology of airway hyperresponsiveness. Curr Allergy Asthma Rep 3: 166171.
  • Boushey HA, Holtzman MJ, Sheller JR, Nadel JA (1980). Bronchial hyperreactivity. Am Rev Respir Dis 121: 389413.
  • Bradding P (2005). Mast cell ion channels. Chem Immunol Allergy 87: 163178.
  • Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R et al. (1994). Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 10: 471480.
  • Bradding P, Walls AF, Holgate ST (2006). The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol 117: 12771284.
  • Brewster CE, Howarth PH, Djukanovic R, Wilson J, Holgate ST, Roche WR (1990). Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 3: 507511.
  • Brightling CE, Ammit AJ, Kaur D, Black JL, Wardlaw AJ, Hughes JM et al. (2005). The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med 171: 11031108.
  • Brightling CE, Symon FA, Birring SS, Bradding P, Pavord ID, Wardlaw AJ (2002). TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis. J Allergy Clin Immunol 110: 899905.
  • Burgess JK, Johnson PRA, Ge Q, Au WW, Poniris MH, McParland BE et al. (2003). Expression of connective tissue growth factor in asthmatic airway smooth muscle cells. Am J Respir Crit Care Med 167: 7177.
  • Cahalan MD, Chandy KG, DeCoursey TE, Gupta S (1985). A voltage-gated potassium channel in human T lymphocytes. J Physiol 358: 197237.
  • Carroll NG, Mutavdzic S, James AL (2002). Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma. Thorax 57: 677682.
  • Castle NA, London DO, Creech C, Fajloun Z, Stocker JW, Sabatier JM (2003). Maurotoxin: a potent inhibitor of intermediate conductance Ca2+-activated potassium channels. Mol Pharmacol 63: 409418.
  • Chandy KG, Wulff H, Beeton C, Pennington M, Gutman GA, Cahalan MD (2004). K+ channels as targets for specific immunomodulation. Trends Pharmacol Sci 25: 280289.
  • Cruse G, Duffy SM, Brightling CE, Bradding P (2006). Functional KCa3.1 K+ channels are required for human lung mast cell migration. Thorax 61: 880885.
  • Devor DC, Singh AK, Lambert LC, DeLuca A, Frizzell RA, Bridges RJ (1999). Bicarbonate and chloride secretion in Calu-3 human airway epithelial cells. J Gen Physiol 113: 743760.
  • Dolmetsch RE, Lewis RS, Goodnow CC, Healy JI (1997). Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature 386: 855858.
  • Dolmetsch RE, Xu K, Lewis RS (1998). Calcium oscillations increase the efficiency and specificity of gene expression. Nature 392: 933936.
  • Duffy SM, Lawley WJ, Conley EC, Bradding P (2001). Resting and activation-dependent ion channels in human mast cells. J Immunol 167: 42614270.
  • Duffy SM, Berger P, Cruse G, Yang W, Bolton SJ, Bradding P (2004). The K+ channel IKCa1 potentiates Ca2+ influx and degranulation in human lung mast cells. J Allergy Clin Immunol 114: 6672.
  • Duffy SM, Cruse G, Lawley WJ, Bradding P (2005). Beta2-adrenoceptor regulation of the K+ channel IKCa1 in human mast cells. FASEB J 19: 10061008.
  • Duffy SM, Cruse G, Brightling CE, Bradding P (2007). Adenosine closes the K+ channel KCa3.1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor. Eur J Immunol 37: 16531662.
  • Duffy SM, Cruse G, Cockerill SL, Brightling CE, Bradding P (2008). Engagement of the EP2 prostanoid receptor closes the K+ channel KCa3.1 in human lung mast cells and attenuates their migration. Eur J Immunol 38: 25482556.
  • Ebina M, Yaegashi H, Chiba R, Takahashi T, Motomiya M, Tanemura M (1990). Hyperreactive site in the airway tree of asthmatic patients revealed by thickening of bronchial muscles. A morphometric study. Am Rev Respir Dis 141: 13271332.
  • Ebina M, Takahashi T, Chiba T, Motomiya M (1993). Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am Rev Respir Dis 148: 720726.
  • Fanger CM, Ghanshani S, Logsdon NJ, Rauer H, Kalman K, Zhou J et al. (1999). Calmodulin mediates calcium-dependent activation of the intermediate conductance KCa channel, IKCa1. J Biol Chem 274: 57465754.
  • Fanger CM, Neben AL, Cahalan MD (2000). Differential Ca2+ influx, KCa channel activity, and Ca2+ clearance distinguish Th1 and Th2 lymphocytes. J Immunol 164: 11531160.
  • Fanger CM, Rauer H, Neben AL, Miller MJ, Rauer H, Wulff H et al. (2001). Calcium-activated potassium channels sustain calcium signaling in T lymphocytes. Selective blockers and manipulated channel expression levels. J Biol Chem 276: 1224912256.
  • Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, Tanasa B et al. (2006). A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441: 179185.
  • Gebhardt T, Gerhard R, Bedoui S, Erpenbeck VJ, Hoffmann MW, Manns MP et al. (2005). beta2-Adrenoceptor-mediated suppression of human intestinal mast cell functions is caused by disruption of filamentous actin dynamics. Eur J Immunol 35: 11241132.
  • Gerlach AC, Gangopadhyay NN, Devor DC (2000). Kinase-dependent regulation of the intermediate conductance, calcium-dependent potassium channel, hIK1. J Biol Chem 275: 585598.
  • Ghanshani S, Wulff H, Miller MJ, Rohm H, Neben A, Gutman GA et al. (2000). Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J Biol Chem 275: 3713737149.
  • Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P et al. (2002). Asthma exacerbations and eosinophil counts. A randomised controlled trial. Lancet 360: 17151721.
  • Grgic I, Eichler I, Heinau P, Si H, Brakemeier S, Hoyer J et al. (2005). Selective blockade of the intermediate-conductance Ca2+-activated K+ channel suppresses proliferation of microvascular and macrovascular endothelial cells and angiogenesis in vivo. Arterioscler Thromb Vasc Biol 25: 704709.
  • Grgic I, Kaistha BP, Paschen S, Kaistha A, Busch C, Si H et al. (2009). Disruption of the Gardos channel (K(Ca)3.1) in mice causes subtle erythrocyte macrocytosis and progressive splenomegaly. Pflugers Arch 458: 291302.
  • Grissmer S, Dethlefs B, Wasmuth JJ, Goldin AL, Gutman GA, Cahalan MD et al. (1990). Expression and chromosomal localization of a lymphocyte K+ channel gene. Proc Natl Acad Sci USA 87: 94119415.
  • Grunnet M, Rasmussen HB, Hay-Schmidt A, Klaerke DA (2003). The voltage-gated potassium channel subunit, Kv1.3, is expressed in epithelia. Biochim Biophys Acta 1616: 8594.
  • Holgate ST (2008). Pathogenesis of asthma. Clin Exp Allergy 38: 872897.
  • Holgate ST, Lackie PM, Davies DE, Roche WR, Walls AF (1999). The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma. Clin Exp Allergy 29 (Suppl. 2): 9095.
  • Hoth M, Penner R (1992). Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature 355: 353356.
  • Johnson P, Burgess J, Underwood P, Au W, Poniris M, Tamm M et al. (2004). Extracellular matrix proteins modulate asthmatic airway smooth muscle cell proliferation via an autocrine mechanism. J Allergy Clin Immunol 113: 690696.
  • Johnson PR, Roth M, Tamm M, Hughes JM, Ge Q, King G et al. (2001). Airway smooth muscle proliferation is increased in asthma. Am J Respir Crit Care Med 164: 474477.
  • Kalman K, Pennington MW, Lanigan MD, Nguyen A, Rauer H, Mahnir V et al. (1998). ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptide. J Biol Chem 273: 3269732707.
  • Kaur D, Berger P, Duffy SM, Brightling CE, Bradding P (2005). Co-cultivation of mast cells and FceRIalpha+ dendritic-like cells from human hip bone marrow. Clin Exp Allergy 35: 226233.
  • Kharrat R, Mabrouk K, Crest M, Darbon H, Oughideni R, Martin-Eauclaire MF et al. (1996). Chemical synthesis and characterization of maurotoxin, a short scorpion toxin with four disulfide bridges that acts on K+ channels. Eur J Biochem 242: 491498.
  • Kohler R, Wulff H, Eichler I, Kneifel M, Neumann D, Knorr A et al. (2003). Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis. Circulation 108: 11191125.
  • Koo GC, Blake JT, Talento A, Nguyen M, Lin S, Sirotina A et al. (1997). Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. J Immunol 158: 51205128.
  • Krug N, Madden J, Redington AE, Lackie P, Djukanovic R, Schauer U et al. (1996). T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am J Respir Cell Mol Biol 14: 319326.
  • Larsson HP, Baker OS, Dhillon DS, Isacoff EY (1996). Transmembrane movement of the shaker K+ channel S4. Neuron 16: 387397.
  • Lewis RS (2001). Calcium signaling mechanisms in T lymphocytes. Annu Rev Immunol 19: 497521.
  • Lin CS, Boltz RC, Blake JT, Nguyen M, Talento A, Fischer PA et al. (1993). Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation. J Exp Med 177: 637645.
  • Lis A, Peinelt C, Beck A, Parvez S, Monteilh-Zoller M, Fleig A et al. (2007). CRACM1, CRACM2, and CRACM3 are store-operated Ca2+ channels with distinct functional properties. Curr Biol 17: 794800.
  • Masoli M, Fabian D, Holt S, Beasley R (2004). The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59: 469478.
  • Matheu MP, Beeton C, Garcia A, Chi V, Rangaraju S, Safrina O et al. (2008). Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block. Immunity 29: 602614.
  • Miotto D, Christodoulopoulos P, Olivenstein R, Taha R, Cameron L, Tsicopoulos A et al. (2001). Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases. J Allergy Clin Immunol 107: 664670.
  • Nicolaou SA, Neumeier L, Peng Y, Devor DC, Conforti L (2007). The Ca(2+)-activated K(+) channel KCa3.1 compartmentalizes in the immunological synapse of human T lymphocytes. Am J Physiol Cell Physiol 292: C1431C1439.
  • O'Byrne PM (2006). Cytokines or their antagonists for the treatment of asthma. Chest 130: 244250.
  • Pedersen KA, Schroder RL, Skaaning-Jensen B, Strobaek D, Olesen SP, Christophersen P (1999). Activation of the human intermediate-conductance Ca(2+)-activated K(+) channel by 1-ethyl-2-benzimidazolinone is strongly Ca(2+)-dependent. Biochim Biophys Acta 1420: 231240.
  • Pena TL, Rane SG (1999). The fibroblast intermediate conductance K(Ca) channel, FIK, as a prototype for the cell growth regulatory function of the IK channel family. J Membr Biol 172: 249257.
  • Pereira LE, Villinger F, Wulff H, Sankaranarayanan A, Raman G, Ansari AA (2007). Pharmacokinetics, toxicity, and functional studies of the selective Kv1.3 channel blocker 5-(4-phenoxybutoxy)psoralen in rhesus macaques. Exp Biol Med (Maywood) 232: 13381354.
  • Prakriya M, Feske S, Gwack Y, Srikanth S, Rao A, Hogan PG (2006). Orai1 is an essential pore subunit of the CRAC channel. Nature 443: 230233.
  • Puddicombe SM, Polosa R, Richter A, Krishna MT, Howarth PH, Holgate ST et al. (2000). Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J 14: 13621374.
  • Rane SG (1991). A Ca2(+)-activated K+ current in ras-transformed fibroblasts is absent from nontransformed cells. Am J Physiol Cell Physiol 260: C104C112.
  • Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM et al. (1992). Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326: 298304.
  • Roth M, Johnson PRA, Borger P, Bihl MP, Rudiger JJ, King GG et al. (2004). Dysfunctional interaction of C/EBP(alpha) and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells. N Engl J Med 351: 560574.
  • Sankaranarayanan A, Raman G, Busch C, Schultz T, Zimin PI, Hoyer J et al. (2009). Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure. Mol Pharmacol 75: 281295.
  • Schmid-Antomarchi H, Schmid-Alliana A, Romey G, Ventura MA, Breittmayer V, Millet MA et al. (1997). Extracellular ATP and UTP control the generation of reactive oxygen intermediates in human macrophages through the opening of a charybdotoxin-sensitive Ca2+-dependent K+ channel. J Immunol 159: 62096215.
  • Schmitz A, Sankaranarayanan A, Azam P, Schmidt-Lassen K, Homerick D, Hansel W et al. (2005). Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases. Mol Pharmacol 68: 12541270.
  • Schwab A, Wulf A, Schulz C, Kessler W, Nechyporuk-Zloy V, Romer M et al. (2006). Subcellular distribution of calcium-sensitive potassium channels (IK1) in migrating cells. J Cell Physiol 206: 8694.
  • Shepherd MC, Duffy SM, Harris T, Cruse G, Schuliga M, Brightling CE et al. (2007). KCa3.1 Ca2+ activated K+ channels regulate human airway smooth muscle proliferation. Am J Respir Cell Mol Biol 37: 525531.
  • Shumilina E, Lam RS, Wolbing F, Matzner N, Zemtsova IM, Sobiesiak M et al. (2008). Blunted IgE-mediated activation of mast cells in mice lacking the Ca(2+)-activated K(+) channel K(Ca)3.1. J Immunol 180: 80408047.
  • Shute JK, Solic N, Shimizu J, McConnell W, Redington AE, Howarth PH (2004). Epithelial expression and release of FGF-2 from heparan sulphate binding sites in bronchial tissue in asthma. Thorax 59: 557562.
  • Si H, Heyken WT, Wolfle SE, Tysiac M, Schubert R, Grgic I et al. (2006). Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel. Circ Res 99: 537544.
  • Siddiqui S, Sutcliffe A, Shikotra A, Woodman L, Doe C, McKenna S et al. (2007). Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis. J Allergy Clin Immunol 120: 813819.
  • Srivastava S, Li Z, Ko K, Choudhury P, Albaqumi M, Johnson AK et al. (2006). Histidine phosphorylation of the potassium channel KCa3.1 by nucleoside diphosphate kinase B is required for activation of KCa3.1 and CD4 T cells. Mol Cell 24: 665675.
  • Srivastava S, Zhdanova O, Di L, Li Z, Albaqumi M, Wulff H et al. (2008). Protein histidine phosphatase 1 negatively regulates CD4 T cells by inhibiting the K+ channel KCa3.1. Proc Natl Acad Sci USA 105: 1444214446.
  • Stocker JW, De FL, Naughton-Smith GA, Corrocher R, Beuzard Y, Brugnara C (2003). ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice. Blood 101: 24122418.
  • Tharp DL, Wamhoff BR, Turk JR, Bowles DK (2006). Upregulation of intermediate-conductance Ca2+-activated K+ channel (IKCa1) mediates phenotypic modulation of coronary smooth muscle. Am J Physiol Heart Circ Physiol 291: H2493H2503.
  • Tharp DL, Wamhoff BR, Wulff H, Raman G, Cheong A, Bowles DK (2008). Local delivery of the KCa3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosis. Arterioscler Thromb Vasc Biol 28: 10841089.
  • Toyama K, Wulff H, Chandy KG, Azam P, Raman G, Saito T et al. (2008). The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans. J Clin Invest 118: 30253037.
  • Vig M, Peinelt C, Beck A, Koomoa DL, Rabah D, Koblan-Huberson M et al. (2006). CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry. Science 312: 12201223.
  • Wenzel S (2005). Severe asthma in adults. Am J Respir Crit Care Med 172: 149160.
  • Wenzel SE, Barnes PJ, Bleecker ER, Bousquet J, Busse W, Dahlen SE et al. (2009). A randomized, double-blind, placebo-controlled study of TNF-(alpha) blockade in severe persistent asthma. Am J Respir Crit Care Med 179: 549558.
  • Wulff H, Miller MJ, Hansel W, Grissmer S, Cahalan MD, Chandy KG (2000). Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant. PNAS 97: 81518156.
  • Wulff H, Calabresi PA, Allie R, Yun S, Pennington M, Beeton C et al. (2003). The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS. J Clin Invest 111: 17031713.
  • Wulff H, Kolski-Andreaco A, Sankaranarayanan A, Sabatier JM, Shakkottai V (2007). Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications. Curr Med Chem 14: 14371457.
  • Yeromin AV, Zhang SL, Jiang W, Yu Y, Safrina O, Cahalan MD (2006). Molecular identification of the CRAC channel by altered ion selectivity in a mutant of Orai. Nature 443: 226229.
  • Zhang SL, Yu Y, Roos J, Kozak JA, Deerinck TJ, Ellisman MH et al. (2005). STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membrane. Nature 437: 902905.